EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Emerging Technologies in Automation Machinery for the Pharmaceutical Industry
Pharmaceutical industry has long been a forerunner on the use of technology where it has proved vital in increasing efficiency quality and safety Automation machinery has become more important over the years due to its ability to efficiently handle manufacturing packaging and distribution challenges Advanced technology is improving automation machinery as an integration tool in the pharmaceutical...
Why Leading Pharma Professionals Rely on the Pharma Focus Europe E-Newsletter
The network of the pharmaceutical and life sciences in Europe is undergoing a radical transformation There are changes in the regulatory environments a rise in the pace of innovation a shift in leadership and a change in the distribution production and development of therapies by the use of digital technologies In this environment no longer will access to timely credible and context rich informati...
Drug Safety in Focus: Challenges and Solutions for Pharma Companies
Drug safety is a paramount concern for pharmaceutical companies worldwide Ensuring the safety and efficacy of medications is not only a legal requirement but also a moral obligation towards patient welfare
Cell and Gene Therapy's Trillion-Dollar Reckoning Is Here
Cell and gene therapies can cure diseases once thought untreatable Yet a string of commercial collapses now suggests that curing the patient and sustaining the business are two very different challenges and the industry is confronting the gap at last
Implementing Quality by Design (QbD) in Pharmaceutical Development: Enhancing Product Quality and Regulatory Compliance
Quality by Design QbD stands as a systematic strategy for pharmaceutical development prioritizing predefined product objectives and emphasizing a thorough understanding of both the product and its manufacturing processes This proactive approach integrates quality seamlessly into the development process championing a sciencedriven
Enhancing Drug Quality and Efficiency with Smart Manufacturing
Smart manufacturing development leads the pharmaceutical industry toward a substantial industrial shift Current regulatory oversight has created production cost challenges that manufacturers face while managing drug safety requirements for highquality medicine production What are the methods by which technology can change the production methods of drugs What position does automation and artificial...
-
Techno Trends
Lilly’s Olomorasib Gains FDA Breakthrough Therapy Status
Eli Lilly and Company has secured Breakthrough Therapy designation from the US Food and Drug Administration FDA for olomorasib an investigational medicine being developed for adults with advanced pancreatic cancer carrying a KRAS GC mutation
-
Projects
Resilience and Lilly Expand Ohio Manufacturing Facility with US$750 Million Investment
Resilience a technologydriven contract development and manufacturing organisation CDMO has expanded its strategic partnership with Eli Lilly and Company to increase domestic production
-
Research Insights
Induction of osteogenic differentiation of MSCs by GSK3β knockdown through GSK3β siRNAs transfection
The development of effective strategies for treating bone defects can be based on gene therapy methods aimed at regulating the differentiation of osteoprogenitor cells One of the approaches is to use siRNA mo
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
-
2
Drug Safety in Focus: Challenges and Solutions for Pharma Companies
Kate Williamson
Drug safety is crucial for pharmaceutical companies, involving challenges like adverse event monitoring, data management, regulatory compliance, and patient reporting. Solutions include advanced pharm...
-
3
Cell and Gene Therapy's Trillion-Dollar Reckoning Is Here
Lakshmi
Cell and gene therapies are transforming medicine, but commercial sustainability remains their greatest challenge. Despite scientific breakthroughs and a rapidly expanding pipeline, many developers fa...
-
4
Implementing Quality by Design (QbD) in Pharmaceutical Development: Enhancing Product Quality and Regulatory Compliance
Kate Williamson
This article explores the implementation of Quality by Design (QbD) in pharmaceutical development, emphasizing its principles and practical applications. QbD ensures consistent product quality, reduce...
-
5
Enhancing Drug Quality and Efficiency with Smart Manufacturing
Sarah Richards
Smart manufacturing revolutionizes pharmaceutical production by integrating automation, AI, IoT, and blockchain for enhanced drug quality, efficiency, and safety. It reduces errors, ensures regulatory...
press releases Read more...
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays
Monod Bio a Seattlebased AIenabled protein design company and SignalChem Biotech Inc a whollyowned subsidiary of Sino Biological Inc SZSE today announced a nonexclusive licensing agreement
Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
Nxera Pharma Co Ltd Nxera or the Company TSE announces that its partner Neurocrine Biosciences Inc Neurocrine has received IND Acceptance from the US Food and Drug Administration
U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
Revolution Medicines Inc a global commercialstage oncology company dedicated to discovering developing and delivering innovative medicines for patients with RASaddicted cancers
HepaRegeniX Receives Orphan Drug Designation for Darizmetinib for the Prevention of Post-Hepatectomy Liver Failure
HepaRegeniX GmbH a clinicalstage biotech company advancing novel therapies for acute and chronic liver diseases today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation
Events Read more...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWS Read more...
4basebio and Genezen Expand Collaboration on Synthetic DNA for Viral Vector Manufacturing
basebio PLC a specialist in enzymatically produced cellfree DNA for genetic medicines has expanded its collaboration with viral vector contract development and manufacturing organisation CDMO Genezen
Cronus Pharma Launches FDA-Approved Bioequivalent R
Cronus Pharma LLC has launched Robenacoxib Injection in the US offering an FDAapproved bioequivalent to ONSIOR robenacoxib Injection for veterinary use
Artis BioSolutions Launches mRNA and LNP Manufacturing Centre in Bilbao, Spain
Artis BioSolutions has launched its Genetic Medicines Centre of Excellence in Bilbao Spain expanding its development and manufacturing capabilities for genetic medicines
Lundbeck and EVERSANA Expand Partnership to Advance AI-Powered Commercialisation
Lundbeck a global pharmaceutical company focused on brain health and EVERSANA a provider of commercial services for the life sciences industry have announced a strategic partnership
Cambrex High Point Completes Regulatory Inspections to Support Commercial API Manufacturing
Cambrex a global contract development and manufacturing organisation CDMO has completed PreApproval Inspections PAIs at its High Point North Carolina facility by the US Food and Drug Administration FDA
ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for Hereditary Angioedema
ADARx Pharmaceuticals Inc has received Fast Track Designation from the US Food and Drug Administration FDA for onvuzosiran an investigational small interfering RNA siRNA therapy being developed to prevent attacks of hereditary angioedema HAE









